SSII / SS Innovations International, Inc. - Zgłoszenia SEC, Raport roczny, o pełnomocnictwie

SS Innovations Announces Completion of World’s Longest-Distance Robotic Telesurgery Cardiac telesurgery performed by Dr. Sudhir Srivastava utilizing the SSi Mantra surgical robotic system from Guyana, at a line distance of approximately 12,500 miles

Exhibit 99.1 SS Innovations Announces Completion of World’s Longest-Distance Robotic Telesurgery Cardiac telesurgery performed by Dr. Sudhir Srivastava utilizing the SSi Mantra surgical robotic system from Guyana, at a line distance of approximately 12,500 miles (20,000 kilometers) to the patient in India Fort Lauderdale, FL – June 4, 2026 – SS Innovations International, Inc. (the “Company” or “SS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 4, 2026 SS INNOVATIONS INTERNATIONAL, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 4, 2026 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Nu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 18, 2026 SS INNOVATIONS INTERNATIONAL, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 18, 2026 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Nu

SS INNOVATIONS INTERNATIONAL, INC. $150,000,000 of Shares of Common Stock Shares of Preferred Stock Debt Securities Offered by the Company 5,016,500 Shares of Common Stock Offered by the Selling Shareholders

Filed Pursuant to Rule 424(b)(5) Registration No. 333-295501 PROSPECTUS SS INNOVATIONS INTERNATIONAL, INC. $150,000,000 of Shares of Common Stock Shares of Preferred Stock Warrants Rights Units Debt Securities Offered by the Company 5,016,500 Shares of Common Stock Offered by the Selling Shareholders This prospectus relates to the offer and sale of up to $150,000,000 in the aggregate of the securi

SS Innovations Reports First Quarter 2026 Financial Results Record quarterly revenue driven by strong growth in SSi Mantra installations and procedures

Exhibit 99.1 SS Innovations Reports First Quarter 2026 Financial Results Record quarterly revenue driven by strong growth in SSi Mantra installations and procedures Fort Lauderdale, FL – May 13, 2026 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and acce

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 13, 2026 SS INNOVATIONS INTERNATIONAL, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 13, 2026 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Nu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-42615 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of regi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 7, 2026 SS INNOVATIONS INTERNATIONAL, INC. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 7, 2026 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Num

SS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress Landmark telesurgery performed in Perth, Australia, more than 4,500 miles from the patient in India, utilizing the S

Exhibit 99.1 SS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress Landmark telesurgery performed in Perth, Australia, more than 4,500 miles from the patient in India, utilizing the SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console Fort Lauderdale, FL – May 7, 2026 – SS Innovations Internationa

SS Innovations Surpasses 10,500 Surgeries Performed with the SSi Mantra Surgical Robotic System

Exhibit 99.1 SS Innovations Surpasses 10,500 Surgeries Performed with the SSi Mantra Surgical Robotic System Fort Lauderdale, FL – May 5, 2026 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that more

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 5, 2026 SS INNOVATIONS INTERNATIONAL, INC. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 5, 2026 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Num

As filed with the Securities and Exchange Commission on May 1, 2026

As filed with the Securities and Exchange Commission on May 1, 2026 Registration No.

CALCULATION OF FILING FEE TABLES SS INNOVATIONS INTERNATIONAL, INC. Table 1: Newly Registered and Carry Forward Securities

Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-3 SS INNOVATIONS INTERNATIONAL, INC.

SS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026 Innovations under development by Company include the SSi Vimana Aero, SSi Avtara and SSi Operion

Exhibit 99.1 SS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026 Innovations under development by Company include the SSi Vimana Aero, SSi Avtara and SSi Operion Fort Lauderdale, FL – April 23, 2026 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 23, 2026 SS INNOVATIONS INTERNATIONAL, INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 23, 2026 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

April 20, 2026

April 20, 2026 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications & Services 100 F Street, N.

SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026 Conference to Unite Global Leaders at the Forefront of Surgical Robotic Innovation

Exhibit 99.1 SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026 Conference to Unite Global Leaders at the Forefront of Surgical Robotic Innovation Fort Lauderdale, FL – April 7, 2026 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 7, 2026 SS INNOVATIONS INTERNATIONAL, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 7, 2026 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0

SS INNOVATIONS INTERNATIONAL, INC. POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION

Exhibit 97.1 SS INNOVATIONS INTERNATIONAL, INC. POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION The Board of Directors (the “Board”) of SS Innovations International, Inc. (the “Company”), acting in the best interest of the Company and its shareholders, has adopted this Policy for the Recovery of Erroneously Awarded Compensation (the “Policy”), which provides for the recovery of certain

SS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and Kenya

Exhibit 99.1 SS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and Kenya Fort Lauderdale, FL – March 30, 2026 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and access

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 30, 2026 SS INNOVATIONS INTERNATIONAL, INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 30, 2026 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 18, 2026 SS INNOVATIONS INTERNATIONAL, INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 18, 2026 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

SS Innovations’ SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the Philippines Company surpasses milestone of 150 cumulative telesurgeries successfully performed with the SSi Mantra

Exhibit 99.1 SS Innovations’ SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the Philippines Company surpasses milestone of 150 cumulative telesurgeries successfully performed with the SSi Mantra Fort Lauderdale, FL – March 18, 2026 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic tech

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 10, 2026 SS INNOVATIONS INTERNATIONAL, INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 10, 2026 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-42615 SS INNOVATI

SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results Strong growth in SSi Mantra installations, procedures and revenues

Exhibit 99.1 SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results Strong growth in SSi Mantra installations, procedures and revenues Fort Lauderdale, FL – March 10, 2026 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible t

SS Innovations Announces Completion of an $18.6 Million Private Placement to Support Growth Initiatives Financing led by Certain of the Company’s Directors and Executive Officers

Exhibit 99.1 SS Innovations Announces Completion of an $18.6 Million Private Placement to Support Growth Initiatives Financing led by Certain of the Company’s Directors and Executive Officers Fort Lauderdale, FL – March 9, 2026 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 6, 2026 SS INNOVATIONS INTERNATIONAL, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 6, 2026 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N

Employment Agreement with Dr, Sudhir Srivastava*+

Exhibit 10.2

As filed with the Securities and Exchange Commission on February 2, 2026

As filed with the Securities and Exchange Commission on February 2, 2026 Registration No.

Form of Representative Warrant*

Exhibit 4.1 THE HOLDER OF THIS WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS WARRANT EXCEPT AS HEREIN PROVIDED AND THE HOLDER OF THIS WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE LATER OF THE DATE THAT THE REGISTRATION STATEMENT (AS DEFINED BELOW) IS DECLARE

Form of Underwriting Agreement*

Exhibit 1.1 SS INNOVATIONS INTERNATIONAL, INC. Underwriting Agreement [●] Shares of Common Stock [●], 2026 Roth Capital Partners, LLC Needham & Company, LLC As the Representatives of the Several Underwriters Named on Schedule I hereto c/o Roth Capital Partners, LLC 888 San Clemente Drive, Suite 400 Newport Beach, CA 92660 c/o Needham & Company, LLC 250 Park Avenue New York, NY 10177 Ladies and Gen

Employment Agreement with Dr. Vishwajyoti P. Srivastava*+

Exhibit 10.3 EMPLOYMENT AGREEMENT This Agreement, effective as of May 1, 2025 (the “Effective Date”), is entered into by and between SS Innovations International Inc., a corporation incorporated under the laws of Florida (the “Company”), and Dr. Vishwajyoti Pascual Srivastava, residing at 28A, Udyan Villa, Triveni Gardens Complex, Gadaipur, Mehrauli, Delhi, India (the “Employee”). WHEREAS the Comp

Offer Letter and Sanction Letter with HDFC Bank*

Exhibit 10.8

Filing Fee Table*

Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-1 SS Innovations International, Inc.

We Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation January 2026 Nasdaq: SSII No Offering of Securities No offer is made by this Company Presentation (this “ Presentation ”)

Exhibit 99.2 We Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation January 2026 Nasdaq: SSII No Offering of Securities No offer is made by this Company Presentation (this “ Presentation ”) to invest in SS Innovations International, Inc . (the “ Company ”) or to purchase any of its securities . Any offer to make such an inves

SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025 Anticipated strong revenue growth driven by higher unit sales of SSi Mantra surgical robotic system

Exhibit 99.1 SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025 Anticipated strong revenue growth driven by higher unit sales of SSi Mantra surgical robotic system Fort Lauderdale, FL – January 13, 2026 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 13, 2026 SS INNOVATIONS INTERNATIONAL, I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 13, 2026 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fil

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 2, 2026 SS INNOVATIONS INTERNATIONAL, IN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 2, 2026 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer

Exhibit 99.1 SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer Fort Lauderdale, FL – January 8, 2026 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the ap

SERVICES AGREEMENT

Exhibit 10.1 SERVICES AGREEMENT This SERVICES AGREEMENT (the “Agreement”) is made and entered into as of January 6, 2026, by and between SS INNOVATIONS INTERNATIONAL, INC., a Florida corporation, (the “Company”) and MILAN RAO, an individual (the “Executive”). RECITALS WHEREAS, the Company desires to secure the services of the Executive, and the Executive desires to furnish such services to the Com

SS Innovations Develops New Instruments to Advance Robotic Surgery in Large, Underserved Patient Segments, including Pediatric and Cardiac Markets Smaller 5-millimeter instruments to be incorporated into the SSi Mantra surgical robotic system

Exhibit 99.1 SS Innovations Develops New Instruments to Advance Robotic Surgery in Large, Underserved Patient Segments, including Pediatric and Cardiac Markets Smaller 5-millimeter instruments to be incorporated into the SSi Mantra surgical robotic system Fort Lauderdale, FL – January 6, 2026 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of in

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 6, 2026 SS INNOVATIONS INTERNATIONAL, IN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 6, 2026 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 16, 2025 SS INNOVATIONS INTERNATIONAL,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 16, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 8, 2025 SS INNOVATIONS INTERNATIONAL, I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 8, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fil

SS Innovations Submits 510(k) Premarket Notification to the FDA for the Company’s SSi Mantra Surgical Robotic System -- Submission covers multiple indications including general, urological, colorectal, gynecological and cardiac surgeries --

Exhibit 99.1 SS Innovations Submits 510(k) Premarket Notification to the FDA for the Company’s SSi Mantra Surgical Robotic System - Submission covers multiple indications including general, urological, colorectal, gynecological and cardiac surgeries - Fort Lauderdale, FL – December 8, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innov

This is a confidential draft submission to the U.S. Securities and Exchange Commission on December 1, 2025. This draft registration statement has not been publicly filed with the U.S. Securities and Exchange Commission and all information herein rema

This is a confidential draft submission to the U.S. Securities and Exchange Commission on December 1, 2025. This draft registration statement has not been publicly filed with the U.S. Securities and Exchange Commission and all information herein remains strictly confidential. Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE S

SS Innovations International Inc. 1600 SE 15th Street, #512 Fort Lauderdale, Florida – 33316, United States of America

Exhibit 10.3 AGREEMENT This Agreement, effective as of May 1, 2025 (the “Effective Date”), is entered into by and between SS Innovations International Inc., a corporation incorporated under the laws of Florida (the “Company”), and Dr. Vishwajyoti Pascual Srivastava, residing at 28A, Udyan Villa, Triveni Gardens Complex, Gadaipur, Mehrauli, Delhi, India (the “Employee”). WHEREAS the Company wishes

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 6, 2025 SS INNOVATIONS INTERNATIONAL, I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 6, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fil

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 6, 2025 SS INNOVATIONS INTERNATIONAL, I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 6, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fil

SS Innovations Announces Successful Completion of First Telesurgery Performed with the Company’s SSi Mantra Tele Surgeon Console Compact New Console Facilitates Performance of Telesurgeries from a Wide Range of Locations, including Physicians’ Office

Exhibit 99.1 SS Innovations Announces Successful Completion of First Telesurgery Performed with the Company’s SSi Mantra Tele Surgeon Console Compact New Console Facilitates Performance of Telesurgeries from a Wide Range of Locations, including Physicians’ Offices Fort Lauderdale, FL – November 6, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a devel

We Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation November 2025 Nasdaq: SSII © 2025 SS INNOVATIONS INTERNATIONAL, INC. 2 No Offering of Securities No offer is made by this

Exhibit 99.1 We Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation November 2025 Nasdaq: SSII © 2025 SS INNOVATIONS INTERNATIONAL, INC. 2 No Offering of Securities No offer is made by this Company Presentation (this “ Presentation ”) to invest in SS Innovations International, Inc . (the “ Company ”) or to purchase any of its

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-42615 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of

SS Innovations Reports Third Quarter 2025 Financial Results Quarterly Revenue Increased 192.5% Year over Year to $12.8 Million Driven by Higher SSi Mantra 3 Unit Sales

Exhibit 99.1 SS Innovations Reports Third Quarter 2025 Financial Results Quarterly Revenue Increased 192.5% Year over Year to $12.8 Million Driven by Higher SSi Mantra 3 Unit Sales Fort Lauderdale, FL – October 28, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 28, 2025 SS INNOVATIONS INTERNATIONAL, I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 28, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fil

SS Innovations to Participate in Upcoming Investor Conferences

Exhibit 99.1 SS Innovations to Participate in Upcoming Investor Conferences Fort Lauderdale, FL – October 21, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that Dr. Sudhir Srivastava, Chairman o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 21, 2025 SS INNOVATIONS INTERNATIONAL, I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 21, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fil

We Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation October 2025 Nasdaq: SSII © 2025 SS INNOVATIONS INTERNATIONAL, INC. 2 No Offering of Securities No offer is made by this C

Exhibit 99.1 We Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation October 2025 Nasdaq: SSII © 2025 SS INNOVATIONS INTERNATIONAL, INC. 2 No Offering of Securities No offer is made by this Company Presentation (this “ Presentation ”) to invest in SS Innovations International, Inc . (the “ Company ”) or to purchase any of its

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 14, 2025 SS INNOVATIONS INTERNATIONAL, I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 14, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fil

SS Innovations Provides U.S. Regulatory Update for the SSi Mantra Surgical Robotic System Company successfully completed a human factors validation study at Johns Hopkins Hospital Anticipates submitting a 510(k) premarket notification to the FDA in t

Exhibit 99.1 SS Innovations Provides U.S. Regulatory Update for the SSi Mantra Surgical Robotic System Company successfully completed a human factors validation study at Johns Hopkins Hospital Anticipates submitting a 510(k) premarket notification to the FDA in the fourth quarter of 2025 Fort Lauderdale, FL – October 2, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 2, 2025 SS INNOVATIONS INTERNATIONAL, IN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 2, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

EMPLOYMENT AGREEMENT

Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is made on September 24, 2025, at Gurgaon, Haryana 122016, India between SUDHIR SRIVASTAVA INNOVATIONS PVT. LTD., a company incorporated according to the laws of India with registered office at 404-405 iLab’s Centre, Phase III, Udyog Vihar, Gurgaon, Haryana 122016, India (the “Company “) and Naveen Kumar Amar S/O Vishand

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 24, 2025 SS INNOVATIONS INTERNATIONAL,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 24, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F

SS Innovations Appoints Naveen Kumar Amar as Chief Financial Officer

Exhibit 99.1 SS Innovations Appoints Naveen Kumar Amar as Chief Financial Officer Fort Lauderdale, FL – September 26, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Naveen Kuma

SS Innovations Announces Successful Completion of World’s First Pediatric Pyeloplasty Telesurgery Utilizing the Company’s SSi Mantra Surgical Robotic System Showcases SSi Mantra’s strengths in robotic telesurgery and opportunity in pediatrics

Exhibit 99.1 SS Innovations Announces Successful Completion of World’s First Pediatric Pyeloplasty Telesurgery Utilizing the Company’s SSi Mantra Surgical Robotic System Showcases SSi Mantra’s strengths in robotic telesurgery and opportunity in pediatrics Fort Lauderdale, FL – September 16, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 16, 2025 SS INNOVATIONS INTERNATIONAL,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 16, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F

SS Innovations Announces Successful Completion of First Robotic Telesurgery Performed from the Company’s MantraM Mobile Robotic Telesurgery Unit Marks another milestone in the Company’s mission to bring advanced surgical robotic care to underserved p

Exhibit 99.1 SS Innovations Announces Successful Completion of First Robotic Telesurgery Performed from the Company’s MantraM Mobile Robotic Telesurgery Unit Marks another milestone in the Company’s mission to bring advanced surgical robotic care to underserved patient populations Fort Lauderdale, FL – September 9, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasd

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 9, 2025 SS INNOVATIONS INTERNATIONAL, INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 9, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 7, 2025 SS INNOVATIONS INTERNATIONAL, INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 7, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

SS Innovations Reports Second Quarter 2025 Financial Results Record Quarterly Revenue of $10.0 Million Driven by Higher SSi Mantra 3 Unit Sales Gross Profit More than Tripled, Driven by Gross Margin Expansion and Revenue Growth

Exhibit 99.1 SS Innovations Reports Second Quarter 2025 Financial Results Record Quarterly Revenue of $10.0 Million Driven by Higher SSi Mantra 3 Unit Sales Gross Profit More than Tripled, Driven by Gross Margin Expansion and Revenue Growth Fort Lauderdale, FL – August 7, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgica

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-42615 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of regis

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 23, 2025 SS INNOVATIONS INTERNATIONAL, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 23, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 22, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N

SS Innovations Announces Completion of World’s First Intercontinental Robotic Cardiac Telesurgery Performed by Dr. Sudhir Srivastava utilizing the Company’s SSi Mantra 3 surgical robotic system Remotely conducted from IRCAD in Strasbourg, France at a

Exhibit 99.1 SS Innovations Announces Completion of World’s First Intercontinental Robotic Cardiac Telesurgery Performed by Dr. Sudhir Srivastava utilizing the Company’s SSi Mantra 3 surgical robotic system Remotely conducted from IRCAD in Strasbourg, France at an unprecedented distance of more than 4,000 miles to the operating room at SAIMS in Indore, India Fort Lauderdale, FL – July 22, 2025 – S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 15, 2025 SS INNOVATIONS INTERNATIONAL, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 15, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N

SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System Continuing strong procedure growth, including an upsurge in telesurgeries

Exhibit 99.1 SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System Continuing strong procedure growth, including an upsurge in telesurgeries Fort Lauderdale, FL – July 15, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surger

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 10, 2025 SS INNOVATIONS INTERNATIONAL, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 10, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N

SS Innovations Announces Completion of World’s First Robotic Telesurgery for Weight Loss with the Company’s SSi Mantra 3 Surgical Robotic System

Exhibit 99.1 SS Innovations Announces Completion of World’s First Robotic Telesurgery for Weight Loss with the Company’s SSi Mantra 3 Surgical Robotic System ● Led by Dr. Mohit Bhandari, a pioneer in bariatric surgery and President of the Institute of Research Against Digestive Cancer (IRCAD) India, the surgery was remotely performed at a distance of 560 miles and executed on-site at Mohak Bariatr

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 16, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N

SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company’s SSi Mantra 3 Surgical Robotic System Surgery performed by Dr. Juan Zuniga at Interhospital in Guayaquil, Ecuador

Exhibit 99.1 SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company’s SSi Mantra 3 Surgical Robotic System Surgery performed by Dr. Juan Zuniga at Interhospital in Guayaquil, Ecuador Fort Lauderdale, FL – June 16, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of inno

We Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation June 2025 Nasdaq: SSII Forward - Looking Statements This Presentation contains forward - looking statements within the mea

Exhibit 99.1 We Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation June 2025 Nasdaq: SSII Forward - Looking Statements This Presentation contains forward - looking statements within the meaning of Section 27 A of the Securities Act of 1933 , as amended and Section 21 E of the Securities Exchange Act of 1934 , as amended . Th

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 3, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Nu

SS Innovations to Ring the Nasdaq Opening Bell on Tuesday, June 3, 2025

Exhibit 99.1 SS Innovations to Ring the Nasdaq Opening Bell on Tuesday, June 3, 2025 Fort Lauderdale, FL – June 2, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company will ring the op

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 2, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Nu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 27, 2025 SS INNOVATIONS INTERNATIONAL, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 27, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Nu

SS Innovations Surpasses Milestone of 4,000 Robotic Surgeries Successfully Performed with the SSi Mantra Surgical Robotic System

Exhibit 99.1 SS Innovations Surpasses Milestone of 4,000 Robotic Surgeries Successfully Performed with the SSi Mantra Surgical Robotic System Fort Lauderdale, FL – May 27, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global popu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 21, 2025 SS INNOVATIONS INTERNATIONAL, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 21, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Nu

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 14, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Nu

SS Innovations Reports First Quarter 2025 Financial Results Record Quarterly Revenue of $5.1 Million Driven by Higher SSi Mantra 3 Unit Sales On Track for July 2025 De Novo Application to the FDA for SSi Mantra 3

Exhibit 99.1 SS Innovations Reports First Quarter 2025 Financial Results Record Quarterly Revenue of $5.1 Million Driven by Higher SSi Mantra 3 Unit Sales On Track for July 2025 De Novo Application to the FDA for SSi Mantra 3 Fort Lauderdale, FL – May 14, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technol

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of regi

SS Innovations to Submit De Novo Application to the FDA for the SSi Mantra 3 Surgical Robotic System for Multiple Indications All Clinical Data Validated by Leading Third-Party CRO for Safety, Feasibility and Efficacy

Exhibit 99.1 SS Innovations to Submit De Novo Application to the FDA for the SSi Mantra 3 Surgical Robotic System for Multiple Indications All Clinical Data Validated by Leading Third-Party CRO for Safety, Feasibility and Efficacy Fort Lauderdale, FL – May 8, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic tec

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 8, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Num

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 5, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Num

SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends

Exhibit 99.1 SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends Fort Lauderdale, FL – May 5, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, toda

SS Innovations Announces Chief Financial Officer Transition

Exhibit 99.1 SS Innovations Announces Chief Financial Officer Transition Fort Lauderdale, FL – May 2, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Arvind Palaniappan as the C

Consulting Agreement between SS Innovations International, Inc. and Trogon Consulting

Exhibit 10.1 TROGON CONSULTING GCX Thomas Manor | Richmond Road | Bangalore 560025 April 1, 2025 Sudhir Srivastava Innovations Pvt Ltd. (SS Innovations Group) 404-405, 3rd Floor, iLabs Info Technology Centre Udyog Vihar Phase III Gurugram (Haryana) India 122016 Attention: Mr. Anup Sethi Subject: Contractual arrangement for CFO services Dear Mr Sethi, Thank you for discussing with us the requiremen

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 30, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

As filed with the Securities and Exchange Commission on April 25, 2025

As filed with the Securities and Exchange Commission on April 25, 2025 Registration No.

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables S-8 (Form Type) SS Innovations International, Inc.

CERT

The Nasdaq Stock Market LLC, 1100 New York Ave. NW, Suite 310E, Washington, DC 20005 Eun Ah Choi Senior Vice President Global Head of Regulatory Operations April 24, 2025 Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Division of Corporation Finance: This is to certify that on April 24, 2025, The Nasdaq Stock Market (the "Exchange"

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 24, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

Fort Lauderdale, FL – April 24, 2025

Exhibit 99.1 Fort Lauderdale, FL – April 24, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company’s common stock has been approved for listing on The Nasdaq Capital Market® (“Nasdaq”). Tr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 SS Innovations International, Inc. (Exact name

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 SS Innovations International, Inc. (Exact name of registrant as specified in its charter) Florida 47-3478854 (State of incorporation or organization) (I.R.S. Employer Identification No.) 1600 SE 15

Compensation Committee Charter(4)

Exhibit 99.2 COMPENSATION COMMITTEE CHARTER OF SS INNOVATIONS INTERNATIONAL, INC. Effective as of January 1, 2025 I. PURPOSE The purpose of the Compensation Committee of the board of directors (the “Board”) of SS Innovations International, Inc. (the “Company”) is: 1. To discharge the responsibilities of the Board relating to compensation of the Company’s directors and executive officers; 2. To ass

Nominating and Corporate Governance Committee Charter(4)

Exhibit 99.3 NOMINATING AND CORPORATE GOVERNANCE COMMITTEE CHARTER OF SS INNOVATIONS INTERNATIONAL, INC. Effective as of January 1, 2025 I. PURPOSE The Nominating and Corporate Governance Committee (the “Nominating Committee”) is appointed by the board of directors (the “Board”) of SS Innovations International, Inc. (the “Company”): (a) to assist the Board by identifying qualified candidates for d

List of Subsidiaries(4)

Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name Jurisdiction of Organization Percentage of Ownership Direct Subsidiaries CardioVentures Inc. Delaware 100% Avra IP Holdings, Inc. Delaware 100% SSI IP Holdings, Inc. Delaware 100% Indirect Subsidiaries Otto Pvt. Ltd. Bahamas 100% owned by CardioVentures Inc. Sudhir Srivastava Innovations Pvt. Ltd. India 91.60% owned directly by Otto Pvt. Ltd.; 7.15% own

Audit Committee Charter(4)

Exhibit 99.1 AUDIT COMMITTEE CHARTER OF SS INNOVATIONS INTERNATIONAL, INC. Effective as of January 1, 2025 I. PURPOSE The Audit Committee shall provide assistance to the Board of Directors (the “Board”) of SS Innovations International, Inc. (the “Company”) in fulfilling the Board’s responsibility to the Company’s shareholders relating to the Company’s accounting and financial reporting practices,

Insider Trading Policy(4)

Exhibit 14.2 CERTIFICATION SS INNOVATIONS INTERNATIONAL, INC. Insider Trading Compliance Program And Insider Trading Policy Acknowledgement Page I have received, read, understand and agree to comply with the SS Innovations International, Inc. Insider Trading Compliance Program including the Insider Trading Policy, which is attached thereto as Appendix I to the accompanying Memorandum from our Chai

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 Commission file number: 000-56608

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 47-3478854 (State or Other Jurisdiction of (I.R.S.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 to Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 20

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 to Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 SS INNOVATIONS INT

SS Innovations Achieves Significant Milestones in 2024 The Company’s award winning SSi Mantra surgical robotic system has completed over 3,500 surgeries and is clinically validated to perform more than 100 different types of surgical procedures The C

Exhibit 99.1 SS Innovations Achieves Significant Milestones in 2024 The Company’s award winning SSi Mantra surgical robotic system has completed over 3,500 surgeries and is clinically validated to perform more than 100 different types of surgical procedures The Company Continues to Build a Strong Foundation for Future Growth FORT LAUDERDALE, FL, March 31, 2025 - SS Innovations International, Inc.

Read Instruction (on back page) Before Preparing Form. Please Print or Type. Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response. 2.50 FORM 12b-25 SEC FILE NUMBER 000-56608 CUSIP NUMBER NOTIFICATION OF LATE FILING 05453U203 (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31,

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 31, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System

EX-99.1 2 ea023586101ex99-1ssinno.htm PRESS RELEASE, DATED MARCH 27, 2025 Exhibit 99.1 SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System ● The SSI Mantra 3 Surgical Robotic System enabled a seamless connection from SS Innovations headquarters in Gurugram, In

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 27, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

SS Innovations Unveils India’s First Mobile Tele-Surgical Unit at SMRSC 2025

Exhibit 99.1 SS Innovations Unveils India’s First Mobile Tele-Surgical Unit at SMRSC 2025 Fort Lauderdale, FL - March 13, 2025 - SS Innovations International, Inc. (OTC:SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced that it unveiled its

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 13, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 to Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 to Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 SS INNOVATIONS INTERNAT

SS Innovations International Launches the 2nd Global Robotic Surgery Conference, SMRSC 2025

Exhibit 99.1 SS Innovations International Launches the 2nd Global Robotic Surgery Conference, SMRSC 2025 Fort Lauderdale, Fla., March 7, 2025: SS Innovations International, Inc. (OTC:SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced the la

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 7, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 to Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the three months ended March 31, 2024 ☐ TRA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 to Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the three months ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 SS INNOVATIONS INTERNATION

JOINT FILING AGREEMENT

EX-1 2 ea023072701ex1ssinnova.htm JOINT FILING AGREEMENT Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities and Exchange Act of 1934, as amended, the undersigned agree that the Statement on Schedule 13G to which this exhibit is attached is filed on behalf of each of them. Each of them is individually eligible to use Schedule 13G to which this exhibit is

JOINT FILING AGREEMENT

Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities and Exchange Act of 1934, as amended, the undersigned agree that the Statement on Schedule 13G to which this exhibit is attached is filed on behalf of each of them.

Unregistered Sales of Equity Securities, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 4, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fil

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 to Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 20

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 to Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 SS INNOVATIONS INT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 to Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 to Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 SS INNOVATIONS INTERNAT

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 13, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fil

SS Innovations International Performs World’s First Robotic Cardiac Telesurgeries with its SSi Mantra 3

Exhibit 99.1 SS Innovations International Performs World’s First Robotic Cardiac Telesurgeries with its SSi Mantra 3 ● A Robotic-Assisted Internal Mammary Artery Harvesting Telesurgery procedure was successfully completed in 58 minutes. ● The world’s first Robotic Beating Heart Totally Endoscopic Coronary Artery Bypass (TECAB) Telesurgery was performed with a latency of only 40 milliseconds (less

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 2 to Form 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 2 to Form 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 47-3478854 (State or

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 11, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi

SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting

Exhibit 99.1 SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting Fort Lauderdale, FL., December 11, 2024 - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, toda

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 10, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi

India’s First CDSCO Certified Robotic System for Telesurgery: SSI Mantra Leads the Way

Exhibit 99.1 India’s First CDSCO Certified Robotic System for Telesurgery: SSI Mantra Leads the Way ● SS Innovations becomes the first and only company in India to receive regulatory approval for Telesurgery and Teleproctoring capabilities of a surgical robotic system, its SSi Mantra, marking a significant achievement in surgical robotics ● SS Innovations reinforces India’s position as a hub for t

December 9, 2024

December 9, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications & Services 100 F Street, N.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 to Form 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 to Form 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 47-3478854 (State or

SSII / SS Innovations International, Inc. / Pai Ranjan R - SCHEDULE 13G Passive Investment

SC 13G 1 ea0223304-13gpaissinnova.htm SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* SS Innovations International, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 05453U203 (CUSIP Number) November 25, 2024 (Date of Event Which Requires Filing of this Statement) Check the

SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia

Exhibit 99.1 SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia ● SS Innovations marks a milestone with the successful completion of Indonesia’s first robotic cardiac surgery using its SSi Mantra Surgical Robotic System. ● Dr. Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations successfully performed the first Beating Heart Totally Endoscopic Coronary Arte

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 26, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of

SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board Tim Adams to serve as Independent Board Director

Exhibit 99.1 SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board Tim Adams to serve as Independent Board Director FORT LAUDERDALE, FL, September 30, 2024) - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessib

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 30, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F

Revolutionizing Surgery: SS Innovations International Inc. Celebrates 2,000 Procedures with its SSi Mantra Surgical Robotic System

Exhibit 99.1 Revolutionizing Surgery: SS Innovations International Inc. Celebrates 2,000 Procedures with its SSi Mantra Surgical Robotic System Fort Lauderdale, FL., September 23 2024 - SS Innovations International, Inc. (the Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 23, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 11, 2024 SS INNOVATIONS INTERNATIONAL,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 11, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F

SS Innovations Conducts Interactive Meeting with the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) and Updates its Expected FDA Approval Timeline

Exhibit 99.1 SS Innovations Conducts Interactive Meeting with the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) and Updates its Expected FDA Approval Timeline Fort Lauderdale, FL., September 11, 2024 - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to m

SS Innovations Welcomes “Father of Surgical Robotics” Dr. Fredric Moll to Board Dr. Moll, founder of Intuitive Surgical, to serve as Vice Chairman.

Exhibit 99.1 SS Innovations Welcomes “Father of Surgical Robotics” Dr. Fredric Moll to Board Dr. Moll, founder of Intuitive Surgical, to serve as Vice Chairman. FORT LAUDERDALE, FL, September 10, 2024) - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordab

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 10, 2024 SS INNOVATIONS INTERNATIONAL,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 10, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of regis

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 3, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi

SS Innovations International, Inc. Announces First Mantra Surgical Robotic System Sale in South America SS Innovations receives Regulatory Approval for Clinical Use in Ecuador SS Innovations Partners with Medical Device Firm Ingemedica S.A. for Distr

Exhibit 99.1 SS Innovations International, Inc. Announces First Mantra Surgical Robotic System Sale in South America SS Innovations receives Regulatory Approval for Clinical Use in Ecuador SS Innovations Partners with Medical Device Firm Ingemedica S.A. for Distribution in Ecuador The first SSi Mantra Surgical Robotic System to be installed at Interhospital, Guayaquil City, Ecuador Fort Lauderdale

Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 30, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

SS Innovations Issues Update on Status of Audit Process and Trading Market for Common Stock

Exhibit 99.1 SS Innovations Issues Update on Status of Audit Process and Trading Market for Common Stock Fort Lauderdale, FL., August 30 2024 - SS Innovations International, Inc. (the Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today issued an updat

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 20, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 14, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

SSI Mantra 3 An Advanced Surgical Robotic © 2024 SS Innovations International, Inc. | Confidential and Proprietary | All Rights Reserved 1 Sudhir Prem Srivastava, MD Founder, Chairman and CEO SS Innovations Group Companies No Offering of Securities N

Exhibit 99.1 SSI Mantra 3 An Advanced Surgical Robotic © 2024 SS Innovations International, Inc. | Confidential and Proprietary | All Rights Reserved 1 Sudhir Prem Srivastava, MD Founder, Chairman and CEO SS Innovations Group Companies No Offering of Securities No offer is made by this Investor Presentation (this “Presentation”) to invest in SS Innovations International, Inc. (the “Company”) or to

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 23, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 18, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

Meet The Latest Innovation In Robotic Surgery: The SSi Mantra-3 New Disruptive System With The Potential To Bring Life-Saving Technology To Every Corner Of The Planet To Be Unveiled in New York For An Exclusive Demonstration

Exhibit 99.1 Meet The Latest Innovation In Robotic Surgery: The SSi Mantra-3 New Disruptive System With The Potential To Bring Life-Saving Technology To Every Corner Of The Planet To Be Unveiled in New York For An Exclusive Demonstration Fort Lauderdale, FL., July 18, 2024 - SS Innovations International, Inc. (the Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 9, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N

SSi Mantra Expands Global Footprint: Nepal's First Surgical Robot Set to Transform Healthcare Sector

Exhibit 99.1 SSi Mantra Expands Global Footprint: Nepal's First Surgical Robot Set to Transform Healthcare Sector ● Baidya & Banskota (B&B) Hospital Installs Nepal's First Surgical Robotic System, India made SSi Mantra ● SSi Mantra integrates cutting edge advancements in robotic surgery, offering surgeons unparalleled precision and control for improved patient outcomes ● SS Innovations helps reinf

SS Innovations Designated “Outstanding Company” Finalist for Surgical Robotics Industry Awards 2024 Annual awards celebrate the best of the surgical robotics industry.

Exhibit 99.1 SS Innovations Designated “Outstanding Company” Finalist for Surgical Robotics Industry Awards 2024 Annual awards celebrate the best of the surgical robotics industry. Fort Lauderdale, FL., June 17, 2024 – Globe Newswire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making worl

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 17, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 11, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

SS Innovations’ SSi Mantra Surgical Robotic System Approved for Use in Indonesia

Exhibit 99.1 SS Innovations’ SSi Mantra Surgical Robotic System Approved for Use in Indonesia Fort Lauderdale, FL., June 11, 2024 – Globe Newswire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today announc

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 29, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N

SS Innovations Engages BDO as its new Auditor SS Innovations believes that the selection of BDO will facilitate uplisting of its common stock to a National Securities Exchange and reflects the Company’s commitment to transparent financial and account

Exhibit 99.1 SS Innovations Engages BDO as its new Auditor SS Innovations believes that the selection of BDO will facilitate uplisting of its common stock to a National Securities Exchange and reflects the Company’s commitment to transparent financial and accounting practices and regulatory compliance FORT LAUDERDALE, Fla., May 31, 2024 (GLOBE NEWSWIRE) – SS Innovations International, Inc. (the “C

SS Innovations’ SSi Mantra Surgical Robotic System Used to Perform 100 Cardiac Surgeries, Signaling Market Expansion ● The SSi Mantra surgical robotic system has surpassed the 100 surgery milestone for robotic cardiac surgery ● SS Innovations maintai

Exhibit 99.1 SS Innovations’ SSi Mantra Surgical Robotic System Used to Perform 100 Cardiac Surgeries, Signaling Market Expansion ● The SSi Mantra surgical robotic system has surpassed the 100 surgery milestone for robotic cardiac surgery ● SS Innovations maintains the world’s only comprehensive robotic cardiac surgery program ● SSi Mantra used in more than 1000 procedures globally ● Company antic

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 21, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of regi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 10, 2024 SS INNOVATIONS INTERNATIONAL, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 10, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N

SS Innovations Achieves Pediatric Milestone with First Infant Pyeloplasty Using SSi Mantra Surgical Robotic System Company’s flagship SSi Mantra surgical device has now been used in more than 1000 procedures

Exhibit 99.1 SS Innovations Achieves Pediatric Milestone with First Infant Pyeloplasty Using SSi Mantra Surgical Robotic System Company’s flagship SSi Mantra surgical device has now been used in more than 1000 procedures Fort Lauderdale, FL., April 29, 2024 - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies

Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 29, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 22, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

SS Innovations International Announces Q1 2024 Company Updates Significant milestones achieved for SSi Mantra Made-in-India surgical robotic system

Exhibit 99.1 SS Innovations International Announces Q1 2024 Company Updates Significant milestones achieved for SSi Mantra Made-in-India surgical robotic system Fort Lauderdale, FL., April 22, 2024 - News Direct - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surger

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 Commission file number: 000-56608

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 47-3478854 (State or Other Jurisdiction of (I.R.S.

List of Subsidiaries(4)

Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name Jurisdiction of Organization Percentage of Ownership Direct Subsidiaries CardioVentures Inc. Delaware 100% Avra IP Holdings, Inc. Delaware 100% SSI IP Holdings, Inc. Delaware 100% Indirect Subsidiaries Otto Pvt. Ltd. Bahamas 100% owned by CardioVentures Inc. Sudhir Srivastava Innovations Pvt. Ltd. India 92.62% owned directly by Otto Pvt. Ltd.; 6.11% own

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 12, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

SS Innovations’ SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement The first Mitral Valve Replacement using the Made in India SSi Mantra Surgical Robotic System was successfully performed at the Narayana Institute of Cardiac

Exhibit 99.1 SS Innovations’ SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement The first Mitral Valve Replacement using the Made in India SSi Mantra Surgical Robotic System was successfully performed at the Narayana Institute of Cardiac Sciences in Bengaluru, India. Fort Lauderdale, FL., March 12, 2024 - News Direct - SS Innovations International, Inc. (the “Company” or “

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 13, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) SS Innovations International, Inc.

SSII / SS Innovations International, Inc. / MOLL FREDERIC H - SC 13G Passive Investment

SC 13G 1 d786743dsc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.  ) * SS Innovations International, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 05453U203 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statem

As filed with the Securities and Exchange Commission on February 14, 2024.

As filed with the Securities and Exchange Commission on February 14, 2024. Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 3841 47-3478854 (State or other jurisdiction of incorporation or organization) (Pr

SSII / SS Innovations International, Inc. / SRIVASTAVA SUDHIR - SCHEDULE 13G Passive Investment

SC 13G 1 ea193005-13gsrivastssinnova.htm SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* SS Innovations International, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 05453U203 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check t

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 1, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi

SS Innovations Demonstrates Groundbreaking Telesurgery Platform at Company’s First Multi-Specialty Robotic Surgical Conference Remote coronary artery suturing performed on animal model via SS Innovations’ telesurgery platform SMRSC 2024 welcomed glob

Exhibit 99.1 SS Innovations Demonstrates Groundbreaking Telesurgery Platform at Company’s First Multi-Specialty Robotic Surgical Conference Remote coronary artery suturing performed on animal model via SS Innovations’ telesurgery platform SMRSC 2024 welcomed global medical experts and innovators to explore the future of robotic surgery Fort Lauderdale, FL., February 1, 2024 - News Direct – SS Inno

SS Innovations Announces Filing of Pre-Submission Application to the Center for Devices and Radiological Health (CDRH) of the United States Food and Drug Administration

Exhibit 99.1 SS Innovations Announces Filing of Pre-Submission Application to the Center for Devices and Radiological Health (CDRH) of the United States Food and Drug Administration Fort Lauderdale, FL., January 26, 2024 - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery a

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 26, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 25, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi

SS Innovations Partners with India’s Leading Medical Equipment Supplier, Medikabazaar Collaboration to facilitate sales of the SSi Mantra Surgical Robotic System to hospitals and medical facilities across India

Exhibit 99.1 SS Innovations Partners with India’s Leading Medical Equipment Supplier, Medikabazaar Collaboration to facilitate sales of the SSi Mantra Surgical Robotic System to hospitals and medical facilities across India Fort Lauderdale, FL., January 25, 2024 - News Direct - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical ro

SS Innovations Achieves Significant Milestones in 2023 -Company’s award winning SSi Mantra surgical robotic system has completed over 550 surgeries and is clinically validated to perform more than 40 different types of surgical procedures- -Company B

Exhibit 99.1 SS Innovations Achieves Significant Milestones in 2023 -Company’s award winning SSi Mantra surgical robotic system has completed over 550 surgeries and is clinically validated to perform more than 40 different types of surgical procedures- -Company Builds Strong Foundation for Future Growth- FORT LAUDERDALE, FL, January 8, 2024 - SS Innovations International, Inc. (the “Company” or “S

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 8, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fil

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 26, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F

SS Innovations Announces Strategic Partnership with Surgical Lab for Distribution in Africa Pan African Medical Device Distributor Surgical Lab to place the SSi Mantra Surgical Robotic System in Healthcare Facilities across the African Continent Surg

Exhibit 99.1 SS Innovations Announces Strategic Partnership with Surgical Lab for Distribution in Africa Pan African Medical Device Distributor Surgical Lab to place the SSi Mantra Surgical Robotic System in Healthcare Facilities across the African Continent Surgical Lab has Begun Registration of SSi Mantra in 27 African countries Fort Lauderdale, FL., December 26, 2023 - News Direct - SS Innovati

© S U D H I R S R I V A S T A V A I N N O V A T I O N S P V T . L T D . | C O N F I D E N T I A L I N F O R M A T I O N 1 SS INNOVATIONS PRODUCT PRESENTATION SUDHIR SRIVASTAVA INNOVATIONS PVT. LTD. - CONFIDENTIAL DISCLAIMERS 2 © S U D H I R S R I V A

Exhibit 99.1 © S U D H I R S R I V A S T A V A I N N O V A T I O N S P V T . L T D . | C O N F I D E N T I A L I N F O R M A T I O N 1 SS INNOVATIONS PRODUCT PRESENTATION SUDHIR SRIVASTAVA INNOVATIONS PVT. LTD. - CONFIDENTIAL DISCLAIMERS 2 © S U D H I R S R I V A S T A V A I N N O V A T I O N S P V T . L T D . | C O N F I D E N T I A L I N F O R M A T I O N No Offering of Securities No offer is ma

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 4, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 27, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F

SS Innovations International SSi Mantra Robotic Surgical System Crosses 500 Successful Procedure Milestone Company Founder and Chairman, Dr. Sudhir P. Srivastava performed complex heart surgery, while simultaneously, Dr. Sudhir K. Rawal, Medical Dire

Exhibit 99.1 SS Innovations International SSi Mantra Robotic Surgical System Crosses 500 Successful Procedure Milestone Company Founder and Chairman, Dr. Sudhir P. Srivastava performed complex heart surgery, while simultaneously, Dr. Sudhir K. Rawal, Medical Director for Rajiv Gandhi Cancer Institute, performed complex Urology Oncology surgery, marking 500 surgery milestone using the SSi Mantra Su

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 27, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 SS Innovations International, Inc. (Exact name

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 SS Innovations International, Inc. (Exact name of registrant as specified in its charter) Florida 47-3478854 (State of incorporation or organization) (I.R.S. Employer Identification No.) 1600 SE 15

SS Innovations Appoints Dr. Sonia Shokeen as Head of Quality and Regulatory Affairs Dr. Shokeen brings over 15 years of medical device experience, including time spent at Johnson & Johnson

Exhibit 99.1 SS Innovations Appoints Dr. Sonia Shokeen as Head of Quality and Regulatory Affairs Dr. Shokeen brings over 15 years of medical device experience, including time spent at Johnson & Johnson Fort Lauderdale, FL., October 30, 2023 - News Direct - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies ded

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 30, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 12, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fil

SS Innovations Enters Licensing Agreement with Johns Hopkins University Company’s flagship SSi Mantra surgical system now installed at the university’s Baltimore campus

Exhibit 99.1 SS Innovations Enters Licensing Agreement with Johns Hopkins University Company’s flagship SSi Mantra surgical system now installed at the university’s Baltimore campus Fort Lauderdale, FL., October 12, 2023 - News Direct - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making rob

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 17, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fil

SS Innovations Recognized on National News As India Celebrates Independence Day News channel, DD India, features SS Innovations’ work in the field of medical technology as an example of Indian excellence

Exhibit 99.1 SS Innovations Recognized on National News As India Celebrates Independence Day News channel, DD India, features SS Innovations’ work in the field of medical technology as an example of Indian excellence Fort Lauderdale, FL., August 17, 2023 - News Direct - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic te

SS Innovations and Dr. Frederic Moll to Deliver Keynote Presentation at the MoneyShow Investment Masters Symposium, Las Vegas Dr. Moll, known as the ‘father of robotic surgery’, is the founder of Intuitive Surgical and creator of the da Vinci surgica

Exhibit 99.1 SS Innovations and Dr. Frederic Moll to Deliver Keynote Presentation at the MoneyShow Investment Masters Symposium, Las Vegas Dr. Moll, known as the ‘father of robotic surgery’, is the founder of Intuitive Surgical and creator of the da Vinci surgical system. Fort Lauderdale, FL., August 8, 2023 - News Direct - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OT

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 8, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

Presentation, dated August 8, 2023

Exhibit 99.2

Employment Agreement with Barry F. Cohen(3)+

Exhibit 10.2 EMPLOYMENT AGREEMENT THIS AGREEMENT, made effective April 14, 2023 (the “Effective Date”), between SS Innovations International Inc., a Florida corporation (hereinafter referred to as the “Company”), and Barry F. Cohen, residing at 1600 SE 15th Street, #512, Ft. Lauderdale, FL 33316, USA (hereinafter referred to as the “Employee”). WHEREAS, the Company wishes to engage the services an

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of regi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 30, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

Promissory Note made in favor of Sushruta Pvt. Ltd.(3)

Exhibit 10.1 THIS CONVERTIBLE PROMISSORY NOTE (THE “NOTE”) AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE APPLICABLE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR UNDER THE SECURITIES LAWS OF ANY STATE. THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT PURPOSES AND NOT WITH A VIEW TO THE DISTRIBUTION THEREOF. THIS NOTE AND THE SECURITIES ISSUABLE UPON

SS Innovations Begins FDA and CE Regulatory Approval Processes for SSi Mantra Flagship Surgical Robotic Device Company retains Elexes, a regulatory and quality compliance firm with deep experience, to advance approval process

Exhibit 99.1 SS Innovations Begins FDA and CE Regulatory Approval Processes for SSi Mantra Flagship Surgical Robotic Device Company retains Elexes, a regulatory and quality compliance firm with deep experience, to advance approval process FORT LAUDERDALE, FL / ACCESSWIRE /August 2, 2023 / SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC:SSII), a developer of innovative s

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 2, 2023 SS INNOVATIONS INTERNATIONAL, INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 2, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

SS Innovations International, Inc. to Present at the Emerging Growth Conference on Wednesday July 12, 2023 SS Innovations invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentati

Exhibit 99.1 SS Innovations International, Inc. to Present at the Emerging Growth Conference on Wednesday July 12, 2023 SS Innovations invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference FORT LAUDERDALE, FL, July 10, 2023 - SS Innovations International, Inc. (the “Company” or “SS Innova

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 10, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A Amendment No. 1 to Form 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 14, 2023 SS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A Amendment No. 1 to Form 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 14, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of I

You’ve Exceeded the SEC’s Traffic Limit

Exhibit 99.2

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 6, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N

SS Innovations International, Inc. © S S I N N O V A T I O N S I N T E R N A T I O N A L I N C . – C O N F I D E N T I A L A N D P R O P R I E T A R Y 1 Improving lives through innovation and care. JUNE 2023

Exhibit 99.1 SS Innovations International, Inc. © S S I N N O V A T I O N S I N T E R N A T I O N A L I N C . – C O N F I D E N T I A L A N D P R O P R I E T A R Y 1 Improving lives through innovation and care. JUNE 2023 DISCLAIMERS © S S I N N O V A T I O N S I N T E R N A T I O N A L I N C . – C O N F I D E N T I A L A N D P R O P R I E T A R Y 2 No Offering of Securities No offer is made by thi

SS Innovations International, Inc. Provides Business Update; Celebrates Achievement of Significant Milestones Company’s flagship SSi Mantra surgical robotic system utilized to perform successful complex cardiac, lung, head and neck surgeries SSi Mant

Exhibit 99.1 SS Innovations International, Inc. Provides Business Update; Celebrates Achievement of Significant Milestones Company’s flagship SSi Mantra surgical robotic system utilized to perform successful complex cardiac, lung, head and neck surgeries SSi Mantra used in first pediatric urology surgery Robotic surgical system has now completed more than 200 surgeries; clinically validated in Ind

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 30, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 15, 2023 SS INNOVATIONS INTERNATIONAL, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 15, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N

SS Innovations International, Inc. (f/k/a Avra Medical Robotics, Inc.) Commences Trading under “SSII” Ticker Symbol and Provides Corporate Update SSII is a Developer of Innovative, Affordable and Accessible Surgical Robotic Technologies

Exhibit 99.1 SS Innovations International, Inc. (f/k/a Avra Medical Robotics, Inc.) Commences Trading under “SSII” Ticker Symbol and Provides Corporate Update SSII is a Developer of Innovative, Affordable and Accessible Surgical Robotic Technologies Ft Lauderdale, Florida – May 15, 2023 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of reg

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events, Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 14, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File

Employment Agreement with Anup Sethi(2)+

Exhibit 10.3 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is made on 16th January 2023 at Gurgaon (India) between Otto Pvt Ltd. a company incorporated according to the laws of the Bahamas with registered office at Davis & Co. The Parthenon Building, No. 17, West Street North, Nassau, Bahamas (the “Company”), and Mr. Anup Kumar Sethi, residing at C-102, Dream Apartments, Plot-14

Employment Agreement with Dr. Vishwajyoti P. Srivastava(2)+

Exhibit 10.2 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is made on 01st Sept 2021 at Gurugram (India) between Otto Pvt Ltd. a company incorporated according to the laws of the Bahamas with registered office at Davis & Co. The Parthenon Building, No. 17, West Street North, Nassau, Bahamas (the “Company”), and Dr. Vishwajyoti Pascual Srivastava, residing at 28A Udyan Villa, Tri

Articles of Amendment to Amended and Restated Articles of Incorporation(2)

Exhibit 3.1 2 3 4 5 6 7

AVRA Medical Robotics Announces Closing of Merger with CardioVentures Announces Management Changes and Name Change to SS Innovations International, Inc.

Exhibit 99.1 AVRA Medical Robotics Announces Closing of Merger with CardioVentures Announces Management Changes and Name Change to SS Innovations International, Inc. Fort Lauderdale, FL, April 19, 2023 - AVRA Medical Robotics, Inc. the “Company”) (OTC: AVMRD), a medical robotics software and artificial intelligence company announced that it has closed on its previously announced acquisition by mer

Employment Agreement with Dr, Sudhir Srivastava(2)

Exhibit 10.1 Employment Agreement This Employment Agreement (Agreement) is entered into on November 11, 2019, by and between: Otto Pvt Ltd, a company incorporated in the Bahamas and having its registered office at Davis & Co, Parthenon Building, 17 West Street North, Nassau, Bahamas (hereinafter referred to as the “Company” which term or expression shall unless excluded by or repugnant to the subj

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 7, 2023 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Number)

Investment Agreement, dated April 7, 2023

Exhibit 10.1 INVESTMENT AGREEMENT THIS INVESTMENT AGREEMENT made and entered into as of April 7, 2023 (this “Investment Agreement”), by and among AVRA MEDICAL ROBOTICS, INC., a Florida corporation (“AVRA”), CARDIOVENTURES INC., a Delaware corporation (“CardioVentures”), DR. SUDHIR PREM SRIVASTAVA (“Dr. Srivastava”) and Dr. FREDERIC H. MOLL (“Dr. Moll”). AVRA, CardioVentures, Dr. Srivastava and Dr.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 Commission file number: 333-21605

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC (Exact name of registrant as specified in its charter) Florida 47-3478854 (State or Other Jurisdiction of (I.R.S. Employe

AVRA Medical Robotics, Inc. (OTC: AVMR) Becomes Current in its SEC Filing Status

EX-99.1 2 ea169561ex99-1avramedi.htm PRESS RELEASE DATED DECEMBER 1, 2022 Exhibit 99.1 AVRA Medical Robotics, Inc. (OTC: AVMR) Becomes Current in its SEC Filing Status For Immediate Release ORLANDO, FL - December 1, 2022 – AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC: AVMR) today announced that as of November 30, 2022, it has filed all required periodic reports with the Securities an

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 1, 2022 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Numb

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of regist

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant

Merger Agreement, dated November 7, 2022

EX-2.1 2 ea168119ex2-1avramedical.htm MERGER AGREEMENT, DATED NOVEMBER 7, 2022 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among AVRA Medical Robotics, Inc., AVRA-SSI Merger Corporation, CardioVentures, Inc. and Dr. Sudhir Srivastava (solely with respect to Sections 3.4, 3.21, 4.4, 5.2, 7.1(a), 7.1(f), 7.2, 8.1 and 9.1) Dated as of November 7, 2022 AGREEMENT AND PLAN OF MERGER This AGREEMENT A

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 7, 2022 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Numb

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of regist

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Commission file number: 333-21605

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC (Exact name of registrant as specified in its charter) Florida 47-3478854 (State or Other Jurisdiction of (I.R.S. Employe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Commission file number: 333-21605

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC (Exact name of registrant as specified in its charter) Florida 47-3478854 (State or Other Jurisdiction of (I.R.S. Employe

ORDER

UNITED STATES OF AMERICA BEFORE THE SECURITIES AND EXCHANGE COMMISSION September 1, 2022 In the Matter of AVRA Medical Robotics, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of regist